https://www.selleckchem.com/pr....oducts/anisomycin.ht
Overall and relapse-free survival rates were significantly better in the ER group than in the non-ER group (p 0.05 and p 0.01, respectively). To date, no patients in the ER group experienced disease recurrence. Additional esophagectomy is a safe and effective treatment modality for patients after noncurative ER. Additional esophagectomy is a safe and effective treatment modality for patients after noncurative ER. The authors hypothesized that cytoreductive surgery (CRS, comprising gastrectomy combined with metastasectomy) i
Like
Comment
Share
